As a subsidiary of listed company Guangxi Wuzhou Zhongheng Group Co., Ltd. and a backbone enterprise in Wuzhou and Guangxi's pharmaceutical industry, the company faces critical IT challenges: single-point failure risks (data/operation security), inflexible scaling, resource shortages from planned business expansions, and complex O&M. To address these, the company plans to deploy a hyper-converged cloud platform featuring high service availability, high data reliability, elastic horizontal scaling, on-demand infrastructure provisioning and unified platform O&M

Driven by the "Made in China 2025" strategy, Wuzhou Pharmaceutical is accelerating its smart manufacturing initiatives. However, the existing IT infrastructure, as the cornerstone of digitalization and intelligence, has become inadequate to support emerging business models. The company aims to adopt cloud computing technologies to lay a robust foundation for smart manufacturing.

Key Challenges

Weak IT Infrastructure：The growing number of systems involved in smart manufacturing exceeds current computing and storage capacities, leading to resource bottlenecks.

Operational Stability & Data Security：Pharmaceutical operations demand non-disruptive system uptime and zero data loss to comply with stringent regulatory requirements.

Data Silos Elimination：Smart manufacturing systems (supply chain, production, quality control) generate fragmented data. A unified platform is needed to aggregate multi-source data for future industrial big data analytics.

Scalability Limitations：Legacy IT architectures impose constraints on storage scalability and I/O performance, hindering future expansions.

1. Deploy a hyper-converged system using 3 servers to host the foundational infrastructure for business systems. The distributed storage within the hyper-converged system provides a unified storage pool for other servers;

2. Unified Resource Management：Integrate and manage existing VMware resource pools through a centralized management platform, enabling consolidated resource governance and operations. This reduces maintenance costs and improves operational efficiency;

3. Cloud Desktop Modernization：Allocate 20 cloud desktops within the existing hyper-converged platform without building a separate desktop resource pool. Future scaling requires only the addition of new nodes.

1. Lower Initial Investment (30% Cost Reduction)：The hyper-converged architecture allows phased construction based on vertical scaling needs for business systems, horizontal storage scaling, and I/O expansion, resulting in 30% lower upfront costs;

2. Simplified Maintenance & Streamlined Operations：A unified platform handles compute and storage O&M, eliminating the need for specialized storage personnel and reducing vendor dependency, thereby lowering TCO;

3. Future-Proof Scalability Aligned with Long-Term Goals：Smart manufacturing requires a platform with elastic horizontal scalability to support evolving operations. The hyper-converged architecture’s linear I/O scalability aligns with Wuzhou Pharmaceutical’s growth roadmap;

4. Enhanced Operational & Data Security：Pharmaceutical operations demand data integrity (e.g., lab/MES systems), long-term data retention, and continuous operations. The hyper-converged system’s dual data replication and high availability elevate the company’s IT security posture.